No Data
Should You Retain Your Conviction in Icon Plc (ICLR)?
Icon Is Maintained at Neutral by Baird
Icon Price Target Cut to $225.00/Share From $249.00 by Baird
Baird Downgrades Icon PLC(ICLR.US) to Hold Rating, Cuts Target Price to $225
Express News | ICON PLC : Leerink Partners Cuts Target Price to $255 From $270
Pharmacovigilance and Drug Safety Software Market Skyrockets to $359.30 Million by 2031 Dominated by Tech Giants - ArisEurope, ICON Plc and Syneos Health | The Insight Partners
ICON Public Limited Company (NASDAQ:ICLR) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
No Data
No Data
